Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic

E-ISSN： 1875-5968|4|2|123-138

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.2, 2004-01, pp. : 123-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Topoisomerases as Anticancer Drug Targets From the Laboratory to the Clinic

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 1, 2001-05 ,pp. : 1-25

Bentham Science Publishers

Access to resources Recommend Favorite

FK506 Binding Proteins as Targets in Anticancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 651-656

Bentham Science Publishers

Access to resources Recommend Favorite

Repair and Translesion DNA Polymerases as Anticancer Drug Targets

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 431-447

Bentham Science Publishers

Access to resources Recommend Favorite

Spinal Cord Compression: From Laboratory to Clinic

By Siegal T.

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1748-1753

Elsevier

Access to resources Recommend Favorite

Novel Anticancer Targets and Drug Discovery in Post Genomic Age

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 1, 2005-01 ,pp. : 53-63

Bentham Science Publishers

Access to resources Recommend Favorite